Your browser doesn't support javascript.
loading
Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.
Kasper, Stefan-Mario; Meinert, Philipp; Kampe, Sandra; Görg, Christoph; Geisen, Christof; Mehlhorn, Uwe; Diefenbach, Christoph.
Affiliation
  • Kasper SM; Department of Anesthesiology, University of Cologne, Germany. stefan-mario.kasper@medizin.uni-koeln.de
Anesthesiology ; 99(1): 42-7, 2003 Jul.
Article in En | MEDLINE | ID: mdl-12826840
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Transfusion / Coronary Artery Bypass / Blood Loss, Surgical / Hydroxyethyl Starch Derivatives / Plasma Substitutes Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Anesthesiology Year: 2003 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Transfusion / Coronary Artery Bypass / Blood Loss, Surgical / Hydroxyethyl Starch Derivatives / Plasma Substitutes Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Anesthesiology Year: 2003 Document type: Article Affiliation country: Country of publication: